These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17694778)

  • 1. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted therapies: a nursing perspective.
    Kay P
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted therapies in lung cancer: a tribute to advancements in clinical research.
    McGee L
    ONS Connect; 2007; 22(8 Suppl):27-8. PubMed ID: 17824552
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapies in colorectal carcinoma: addressing toxicities associated with EGFR inhibitors.
    Biedrzycki BA
    ONS Connect; 2007; 22(8 Suppl):33-4. PubMed ID: 17824555
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted therapies in breast cancer: challenging questions from oncology nurses.
    Becze E
    ONS Connect; 2007; 22(8 Suppl):31-2. PubMed ID: 17824554
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in cancer therapy: targeted agents.
    Gaguski ME; Begyn P
    Nurs Manage; 2008 May; 39(5):45-8. PubMed ID: 18460908
    [No Abstract]   [Full Text] [Related]  

  • 9. EGFR as a target: rationale for therapy.
    Wujcik D
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):5-9. PubMed ID: 16616281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2003 May; 9(5):1579-89. PubMed ID: 12738709
    [No Abstract]   [Full Text] [Related]  

  • 11. Review: side effects of approved molecular targeted therapies in solid cancers.
    Widakowich C; de Castro G; de Azambuja E; Dinh P; Awada A
    Oncologist; 2007 Dec; 12(12):1443-55. PubMed ID: 18165622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted cancer. These "smart weapons" hit cancer in novel ways.
    Held-Warmkessel J
    Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are targeted therapies really targeted?
    Schilsky RL
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
    Tortora G; Ciardiello F; Gasparini G
    Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic principles of signal transduction].
    Yarden Y
    Onkologie; 2005 Oct; 28 Suppl 4():14-7. PubMed ID: 16205100
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging therapies in head and neck cancers: EGFR inhibitors.
    Held-Warmkessel J
    ONS News; 2006; 21(8 Suppl):61-2. PubMed ID: 16925156
    [No Abstract]   [Full Text] [Related]  

  • 17. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents.
    Holash J; Thurston G; Rudge JS; Yancopoulos GD; Adjei AA; Bergers G; Pytowski B; Pegram M; Gordon MS
    Cancer Metastasis Rev; 2006 Jun; 25(2):243-52. PubMed ID: 16770536
    [No Abstract]   [Full Text] [Related]  

  • 19. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Responses to targeted therapies: lung cancer].
    Brambilla E
    Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.